Group 1 - The Rosen Law Firm is reminding purchasers of Tronox Holdings plc common stock from February 12, 2025, to July 30, 2025, about the lead plaintiff deadline on November 3, 2025 [1] - Investors who purchased Tronox common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6] Group 2 - The lawsuit alleges that Tronox provided misleading statements about its commercial division and failed to accurately forecast demand for its products, leading to a decline in sales and increased costs [5] - The firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]

Financing Transaction - Apollo and Silver led a direct loan of approximately $900 million to Vantage Specialty Chemicals [1] - The $900 million loan replaces Vantage Specialty Chemicals' existing bank-arranged financing [1] Company Information - Vantage Specialty Chemicals received the $900 million direct loan [1]

Core Viewpoint - A class action lawsuit has been filed against Dow Inc. for allegedly failing to disclose critical information regarding its business prospects, leading to significant financial losses for shareholders [1][2]. Group 1: Allegations and Financial Performance - The lawsuit claims that Dow overstated its ability to handle macroeconomic challenges and maintain financial flexibility for dividends, while understating the negative impacts of competitive pressures, declining global sales, and product oversupply [2]. - On June 23, 2025, BMO downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, resulting in a 3.21% drop in stock price to $26.87 [3]. - Dow reported disappointing Q2 2025 results on July 24, 2025, with a non-GAAP loss per share of $0.42, exceeding analyst expectations of a loss between $0.17 and $0.18. Net sales were $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million. Additionally, Dow announced a 50% cut in its dividend, causing a 17.45% drop in stock price to $25.07 [4]. Group 2: Class Action Participation - Shareholders may be eligible to participate in the class action against Dow Inc. and can contact Robbins LLP if they wish to serve as lead plaintiff [5]. - The lead plaintiff represents other class members in directing the litigation, and shareholders can remain absent class members if they choose not to participate [5]. Group 3: Company Background - Dow Inc. is an American materials science company that serves various industries, including packaging, infrastructure, mobility, and consumer applications [1].

Core Viewpoint - Celanese, a chemicals company, has seen its stock drop over 70% despite previously strong earnings during the post-Covid boom, leading to uncertainty about its future performance [1]. Group 1: Company Overview - Celanese operates through two segments: Engineered Materials, which accounts for 55% of 2024 sales, and Acetyl Chain, contributing 45% [1]. Group 2: Market Performance - The company recorded spectacular earnings during the post-Covid period but has since faced a significant decline in stock value [1].

Market Overview - The S&P 500 and Nasdaq are relatively unchanged as investors await the Federal Reserve's meeting next week, with expectations for a 25 basis point interest rate cut following a warm inflation report and weaker labor data [1][1][1] Company Updates - Boeing shares fell by 1.4% after a 3.3% drop previously, due to CEO Kelly Ortberg's comments on delays in 777X aircraft certification. The stock's pullback is viewed as a buying opportunity, as it does not affect the company's cash flow trajectory [1][1][1] - Broadcom's shares increased after Mizuho raised its price target from $355 to $410, driven by positive AI revenue forecasts and production ramp-up with existing and new clients like OpenAI. The company plans to trim its position due to the stock's significant movement since the last report [1][1][1] Upcoming Events - DuPont is set to hold an investor day to discuss its upcoming spinoff of the electronics business, with a buy-equivalent rating and a price target of $90 per share [1][1][1] - CrowdStrike will host its Falcon Con conference following a disappointing stock reaction despite a strong third quarter, with an upgraded rating and a price target of $520 [1][1][1]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Tronox To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Tronox between February 2, 2025 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Faruqi & ...

Core Insights - DuPont de Nemours, Inc. has a market capitalization of $31.9 billion and operates in specialty materials and chemicals, serving various markets including electronics, industrial, healthcare, water, and protection [1] - The company is categorized as a large-cap stock due to its valuation exceeding $10 billion, with strengths in intellectual property, strong margins, and exposure to high-growth markets [2] Stock Performance - DuPont's shares have declined 13.4% from a 52-week high of $90.06 reached on September 27, 2024, and have decreased 12.4% over the past three months, underperforming the Materials Select Sector SPDR Fund's 5.2% rise [3] - Year-to-date, DuPont's stock is up 2.3%, lagging behind the XLB's 10.1% return, and has dipped 2.4% over the past 52 weeks compared to XLB's 1.8% rise [4] Recent Developments - On August 29, DuPont announced a definitive agreement to sell its Aramids business, including Kevlar® and Nomex®, to Arclin for approximately $1.8 billion, expected to close in Q1 2026 pending regulatory approvals [5] - The transaction is anticipated to provide DuPont with about $1.2 billion in pre-tax cash proceeds, a $300 million note receivable, and a 17.5% equity stake in the future Arclin entity valued at roughly $325 million at closing [5] - Management indicated that this transaction enhances DuPont's strategic focus and growth profile, but the market reaction was negative, with shares dipping 1.5% in the following trading session [6]

Group 1 - The polyethylene market is expected to experience positive price action in September after a decline in the second quarter due to tariff uncertainties, with no significant inventory build observed [1] - The company has reported stable volumes, strong export capabilities, and low-cost positions in the United States during the third quarter [2] - Ongoing tariff and geopolitical uncertainties have impacted demand patterns, particularly in the industrial infrastructure and durable goods sectors [2] Group 2 - A reduction in interest rates is anticipated to aid recovery in depressed end markets such as housing and durable goods, which are sensitive to rates and affordability [3] - The company is adding additional capacity to its net-zero petrochemical project, Path2Zero production complex, in Alberta, Canada, with an update expected by year-end [3] - The project timeline has been delayed by one to two years due to unfavorable market conditions, with construction initially planned to begin in 2024 [4]

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Dow Inc. ("Dow†or the "Company†) (NYSE: DOW) securities between January 30, 2025 and July 23, 2025, inclusive (the "Class Period†). IF YOU SUFFERED A LOSS ON YOUR DOW INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UN. ...

US equity futures have a slight bid into today's CPI print - the last key macro datapoint ahead of next week's rate decision - rising to another daily record high, let by Tech. As of 8:10am, S&P futures rise 0.2% after back-to-back all-time highs while Nasdaq 100 futures rise 0.3% with AAPL and AMZN leading the Mag7 higher and ORCL +1.4% after its +36% move yesterday. In a familiar pattern this week, Cyclicals are outperforming Defensives pre-mkt. European stocks also drifted higher while Chinese stocks cap ...